Targeted RT study: preliminary results on acute toxicity of targeted therapies and radiotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026193

Enrollment

500

Registered

2022-12-27

Start date

2020-03-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

all malignant diseases which are treated with targeted therapy

Interventions

Group 1: Patients receiving radiotherapy and simultaneous (or closely timed) targeted therapy.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: targeted therapy - simultaneously and sequentially with radiation therapy

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Prospective systematic recording of the toxicity profile of targeted drugs during radiotherapy in a registry to improve the evidence base.	—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 6, 2026